Team presents new resource at World Health Summit

This international forum and leading global health conference brings together stakeholders from politics, science, the private sector, and civil society. The aim of this event, held between October 13 to 15,   is ‘to set the agenda for a healthier future by inspiring innovative solutions for better health and well-being for all’.

Dr Gnegel and Dr Caillet’s presentation entitled ‘Choosing portable screening devices for the detection of substandard and falsified medicines - an online resource to guide national medicines regulators‘ and demonstrated the DAshboard for Field-pOrtable screening Devices usIng scientific Literature, DAFODIL, a resource developed by the Group. Their presentation was embedded in a session organised by the Association of Research-Based Pharmaceutical Companies (vfa), the Ecumenial Pharmaceutical Network (EPN) and the University of Tübingen, and chaired by Prof Lutz Heide of the University of Tübingen, Germany.

The session included further talks by 

• Prof Raffaella Ravinetto of the Institute of Tropical Medicine in Antwerp, Belgium, 
• Rutendo Kuwana the head of the WHO Incidents and Substandard/Falsified Medical Products unit, 
• Prof Eliangiringa Kaale of the Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania, and 
• Richard Neci the executive director of the Ecumenical Pharmaceutical Network (EPN), Kenya.

The talks were followed by a questions & answers session, with lots of interest in DAFODIL.

Over 3,500 participants were present at the World Health Summit and 21,000 participants also joined online. 

During the Summit’s ‘Signature event’, countries from all over the world pledged a total of 1 billion US dollars to help WHO fulfil its ‘Health for All’ mandate (2025-2028), which aims to prevent 40 million avoidable deaths caused by diseases over the next four years.